Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)
China flag China · Delayed Price · Currency is CNY
16.64
+0.01 (0.06%)
Feb 3, 2026, 3:04 PM CST

SHE:002020 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
3,9254,0863,9203,7173,4013,214
Other Revenue
72.7372.7378.8962.8165.0644.25
3,9984,1593,9993,7803,4673,258
Revenue Growth (YoY)
-6.63%3.99%5.79%9.04%6.40%-10.66%
Cost of Revenue
2,0512,0981,9881,7741,5471,277
Gross Profit
1,9472,0612,0112,0061,9201,981
Selling, General & Admin
757.17916.47994.61984.94970.721,178
Research & Development
388.32383.34400.79367.04334.14257.91
Other Operating Expenses
115.333.5230.0936.1926.5728.02
Operating Expenses
1,2681,3461,4321,3921,3421,462
Operating Income
679.01714.56579.08613.8577.8519.31
Interest Expense
-5.52-7.74-7.31-6.01-4.97-6
Interest & Investment Income
77.9880.266.7185.0596.2979.73
Currency Exchange Gain (Loss)
2.932.933.4314.43-3.84-9.77
Other Non Operating Income (Expenses)
-7.91-3.4-0.97-3.21-7.19-9.77
EBT Excluding Unusual Items
746.49786.54640.94704.06658.09573.49
Gain (Loss) on Sale of Investments
-43.19-42.3724.4410.157.23131.49
Gain (Loss) on Sale of Assets
1.932.596.860.61-0.48-0.04
Asset Writedown
-8.4-0.07-0.01-0.07-8.42-0.51
Other Unusual Items
135.697.335.8135.5643.1254.54
Pretax Income
832.43843.98708.04750.32699.54758.98
Income Tax Expense
112.45124.8584.6282.4981.57105.65
Earnings From Continuing Operations
719.98719.13623.42667.82617.96653.33
Minority Interest in Earnings
-7.42-7.16-4.52-5.57-5.42-0.26
Net Income
712.56711.96618.9662.25612.54653.07
Net Income to Common
712.56711.96618.9662.25612.54653.07
Net Income Growth
-1.21%15.04%-6.55%8.12%-6.21%25.50%
Shares Outstanding (Basic)
831858860860817796
Shares Outstanding (Diluted)
831858860860817796
Shares Change (YoY)
-3.25%-0.21%-0.06%5.31%2.55%-6.90%
EPS (Basic)
0.860.830.720.770.750.82
EPS (Diluted)
0.860.830.720.770.750.82
EPS Growth
2.11%15.28%-6.49%2.67%-8.54%34.80%
Free Cash Flow
501.59475.52273.32340.2-33.37179.21
Free Cash Flow Per Share
0.600.550.320.40-0.040.23
Dividend Per Share
0.3500.3500.3000.3000.3000.292
Dividend Growth
16.67%16.67%--2.84%-
Gross Margin
48.71%49.56%50.30%53.06%55.39%60.80%
Operating Margin
16.98%17.18%14.48%16.24%16.67%15.94%
Profit Margin
17.82%17.12%15.48%17.52%17.67%20.04%
Free Cash Flow Margin
12.55%11.43%6.83%9.00%-0.96%5.50%
EBITDA
1,006989.48784.87766.56713.89642.51
EBITDA Margin
25.16%23.79%19.63%20.28%20.59%19.72%
D&A For EBITDA
326.78274.93205.79152.76136.09123.2
EBIT
679.01714.56579.08613.8577.8519.31
EBIT Margin
16.98%17.18%14.48%16.24%16.67%15.94%
Effective Tax Rate
13.51%14.79%11.95%10.99%11.66%13.92%
Revenue as Reported
3,9984,1593,9993,7803,4673,258
Advertising Expenses
----5.13-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.